Evidence map›Paper›PMID 32820247›Full record

SynthesisGenetics in medicine : official journal of the American College of Medical Genetics2021

Germline variants in HEY2 functional domains lead to congenital heart defects and thoracic aortic aneurysms.

Eva S van Walree, Gregor Dombrowsky, Iris E Jansen, Maša Umićević Mirkov, Rob Zwart, Aho Ilgun, Dongchuan Guo, Sally-Ann B Clur, Ahmed S Amin, Jeanne E Savage and 16 more

Erratum issuedOpen access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Defects inFrontiers in genetics · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. SomaticExperimental and therapeutic medicine · 2024
    Article
  7. Human Genetics of Ventricular Septal Defect.Advances in experimental medicine and biology · 2024
    Article
  8. Discovery ofAmerican journal of translational research · 2024
    Article
  9. The Roles of Histone Lysine Methyltransferases in Heart Development and Disease.Journal of cardiovascular development and disease · 2023
    Review
  10. Discovery ofBiology · 2023
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 11 institutions in 4 countries.

Eva S van WalreeDepartment of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. e.s.van.walree@vu.nl.ORCID http://orcid.org/0000-0003-3340-5875
Gregor DombrowskyDepartment of Congenital Heart Disease and Pediatric Cardiology, Universitätsklinikum Schleswig-Holstein Kiel, Kiel, Germany.
Iris E JansenDepartment of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University, Amsterdam, The Netherlands.
Maša Umićević MirkovDepartment of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University, Amsterdam, The Netherlands.
Rob ZwartDepartment of Medical Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Aho IlgunDepartment of Medical Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Dongchuan GuoDepartment of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
Sally-Ann B ClurDepartment of Pediatric Cardiology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Ahmed S AminDepartment of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Jeanne E SavageDepartment of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University, Amsterdam, The Netherlands.
Allard C van der WalDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Quinten WaisfiszDepartment of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands.
Alessandra MaugeriDepartment of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands.
Anna WilsdonSchool of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, United Kingdom.
Frances A Bu'LockEast Midlands Congenital Heart Centre and University of Leicester, Glenfield Hospital, Leicester, United Kingdom.
Matthew E HurlesWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.
Sven DittrichDepartment of Pediatric Cardiology, University of Erlangen-Nürnberg, Erlangen, Germany.
Felix BergerGerman Heart Center Berlin, Department of Congenital Heart Disease, Pediatric Cardiology, Berlin, Germany.
Enrique Audain MartinezDepartment of Congenital Heart Disease and Pediatric Cardiology, Universitätsklinikum Schleswig-Holstein Kiel, Kiel, Germany.
Vincent M ChristoffelsDepartment of Medical Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Marc-Philip HitzDepartment of Congenital Heart Disease and Pediatric Cardiology, Universitätsklinikum Schleswig-Holstein Kiel, Kiel, Germany.
Dianna M MilewiczDepartment of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
Daniëlle PosthumaDepartment of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University, Amsterdam, The Netherlands.
Hanne Meijers-HeijboerDepartment of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Alex V Postma *Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Inge B Mathijssen *Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. i.b.mathijssen@amsterdamumc.nl.
Amsterdam University Medical Centers · NLAmsterdam Neuroscience · NLUniversity Hospital Schleswig-Holstein · DEThe University of Texas Health Science Center at Houston · USVrije Universiteit Amsterdam · NLDeutsches Herzzentrum der Charité · DEEmma Kinderziekenhuis · NLFriedrich-Alexander-Universität Erlangen-Nürnberg · DEGlenfield Hospital · GBUniversity of Nottingham · GBWellcome Sanger Institute · GB

Funding

The Training CoreP50HL083794 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILEWICZ, DIANNA M · 2006 to 2010
$11.3M
Genetic Predisposition To Thoracic Aortic Aneurysms/DissectionsR01HL109942 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILEWICZ, DIANNA M · 2012 to 2023
$7.5M
Genetic Basis of Aortic Aneurysms/DissectionsR01HL062594 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILEWICZ, DIANNA M · 2002 to 2009
$3.2M
NHLBI NIH HHS P50 HL083794NHLBI NIH HHS R01 HL062594NHLBI NIH HHS R01 HL109942
6 · The paper itself

Abstract

purposeIn this study we aimed to establish the genetic cause of a myriad of cardiovascular defects prevalent in individuals from a genetically isolated population, who were found to share a common ancestor in 1728.

methodsTrio genome sequencing was carried out in an index patient with critical congenital heart disease (CHD); family members had either exome or Sanger sequencing. To confirm enrichment, we performed a gene-based association test and meta-analysis in two independent validation cohorts: one with 2685 CHD cases versus 4370 . These controls were also ancestry-matched (same as FTAA controls), and the other with 326 cases with familial thoracic aortic aneurysms (FTAA) and dissections versus 570 ancestry-matched controls. Functional consequences of identified variants were evaluated using expression studies.

resultsWe identified a loss-of-function variant in the Notch target transcription factor-encoding gene HEY2. The homozygous state (n = 3) causes life-threatening congenital heart defects, while 80% of heterozygous carriers (n = 20) had cardiovascular defects, mainly CHD and FTAA of the ascending aorta. We confirm enrichment of rare risk variants in HEY2 functional domains after meta-analysis (MetaSKAT p = 0.018). Furthermore, we show that several identified variants lead to dysregulation of repression by HEY2.

conclusionA homozygous germline loss-of-function variant in HEY2 leads to critical CHD. The majority of heterozygotes show a myriad of cardiovascular defects.

Indexed as

Aortic Aneurysm, ThoracicHeart Defects, CongenitalBasic Helix-Loop-Helix ProteinsGenetic Predisposition to DiseaseGerm CellsHumansPedigreeRepressor ProteinsBasic Helix-Loop-Helix ProteinsHEY2 protein, humanRepressor Proteinscardiovascular defectscongenital heart defectHEY2thoracic aortic aneurysm

Identifiers

PMID32820247
PMCPMC8804301
OpenAlexW3081330900

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.